Met Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 14-12-2024
- Paid Up Capital ₹ 2.86 Cr
as on 14-12-2024
- Company Age 10 Year, 10 Months
- Open Charges ₹ 9.00 Cr
as on 14-12-2024
About Met Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.86 Cr.
The company currently has active open charges totaling ₹9.00 Cr.
Nanne Mahammad, Hemanth Polavaram, and Mohana Gopinath serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PTC092717
- Company No.
092717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2014
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Met Therapeutics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohana Gopinath  | Director | 03-Feb-2014 | Current |
| Hemanth Polavaram | Director | 03-Feb-2014 | Current |
| Nanne Mahammad | Director | 03-Feb-2014 | Current |
Financial Performance of Met Therapeutics.
Enhance accessibility to Met Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Met Therapeutics?
Unlock access to Met Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bioviz Technologies Private LimitedActive 17 years 7 monthsNanne Mahammad and Hemanth Polavaram are mutual person
Bvz Pharma Private LimitedActive 10 years 11 monthsNanne Mahammad and Hemanth Polavaram are mutual person
- Sreemanomai Tech Solutions Private LimitedActive 3 years 3 months
Hemanth Polavaram is a mutual person
- Yaj Institute Of Management And Applied ResearchActive 14 years 12 days
Hemanth Polavaram is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 12 Sep 2014 | ₹9.00 Cr | Open |
How Many Employees Work at Met Therapeutics?
Unlock and access historical data on people associated with Met Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Met Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Met Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
